Principal Investigator, Department of Cardiology, Peking University Third Hospital Wenyao Wang, MD, PhD Associate Researcher Department of Cardiology, Peking University Third Hospital Education PhD, Peking Union Medical College, 2011.08-2016.07 Visiting Scholar, New York Institute of Technology, 2014.09-2015.06 Bachelor's Degree, Qingdao University School of Medicine, 2006.08-2011.07 Research and Professional Experience 2021.12-Present, Peking University Third Hospital, Associate Researcher 2016.08-2021.11, Fuwai Hospital, Chinese Academy of Medical Sciences, Resident and Attending Physician Awards and Honors 2023 Huaxia Medical Science and Technology Award, First Prize in Science and Technology (Second Contributor) 2023 "Beijing Outstanding Young Talent" (Beijing Municipal Science and Technology Commission) 2021 "Outstanding Young and Middle-aged Cardiovascular Specialist - Clinical Research Innovation Award" (Chinese Medical Association) 2020 "Beijing Nova Program" (Beijing Municipal Science and Technology Commission) Dr. Wang has long been engaged in research in two fields: the pathogenesis of cardiometabolic diseases and antithrombotic therapy in high-risk patients with coronary artery disease. In previous studies, he identified thyroid dysfunction as an independent risk factor for the onset and progression of cardiovascular diseases, established risk stratification tools to guide clinical practice, and further explored the underlying molecular mechanisms and therapeutic interventions. He also developed safe and effective individualized antiplatelet treatment strategies for high-risk patients with coronary artery disease. His research findings have been published in over 30 SCI-indexed papers, contributed to 4 monographs, and led to 3 invention patent applications. As principal investigator, he has led one project funded by the National Natural Science Foundation of China (General Program), one Youth Project, and one project funded by the Beijing Municipal Science and Technology Commission. As a key research member, he has participated in multiple scientific research projects, including the National Key Research and Development Program during the 13th Five-Year Plan period, the National Science and Technology Support Program during the 12th Five-Year Plan period, and the Major Research Plan of the National Natural Science Foundation of China. He is currently a committee member of the Beijing Precision Medicine Society and serves as a reviewer for several international academic journals.